Home Cart Sign in  
Chemical Structure| 1443763-60-7 Chemical Structure| 1443763-60-7

Structure of Empesertib
CAS No.: 1443763-60-7

Chemical Structure| 1443763-60-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAY 1161909 inhibits Mps1 kinase activity with IC50 of < 1 nM when assay with 10 μM ATP, with IC50 of < 1.9 nM when assay with 2 mM ATP.

Synonyms: Bay 1161909; Mps1-IN-5

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Empesertib

CAS No. :1443763-60-7
Formula : C29H26FN5O4S
M.W : 559.61
SMILES Code : FC1=CC=C([C@@H](C)C(NC2=CC=C(C3=CN4N=C(NC5=CC=C(S(C)(=O)=O)C=C5OC)N=C4C=C3)C=C2)=O)C=C1
Synonyms :
Bay 1161909; Mps1-IN-5
MDL No. :MFCD28902188
InChI Key :NRJKIOCCERLIDG-GOSISDBHSA-N
Pubchem ID :71599640

Safety of Empesertib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Empesertib

cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF-7 cells 0-1000 nM 72 hours Evaluate the cytotoxicity of Empesertib on MCF-7 cells Oncol Rep. 2024 Aug;52(2):101
HMEC cells 0-1000 nM 72 hours Evaluate the cytotoxicity of Empesertib on HMEC cells Oncol Rep. 2024 Aug;52(2):101
MDA-MB-231 cells 0-1000 nM 72 hours Evaluate the cytotoxicity of Empesertib on MDA-MB-231 cells Oncol Rep. 2024 Aug;52(2):101

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.79mL

0.36mL

0.18mL

8.93mL

1.79mL

0.89mL

17.87mL

3.57mL

1.79mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories